Kenneth Blum, Ph.D., David Siwicki, MD, and Justin Jones, MBA, CHFP, CEO Geneus Health

What is it about a good selfie that we find so endearing to our hearts? Thousands of tiny pixels, drawing from a palate of hundreds of different colors, coordinated on a smartphone screen in such a way that makes us laugh or cry, smile or frown, or feel some other emotions. Selfies often tell an untold or underlying story words simply cannot do justice to. They’ve changed the way we view ourselves, the people closest to us and the world around us in real time.

Even professional photographers are getting in on the act. This relatively new technology has created a whole new genre of art and photography.

But every now and then you take a selfie and it comes out a bit distorted or blurred. Something just doesn’t seem right in the foreground or background. When you take a closer look at the pixels that make up the image, they appear dull and less defined. It doesn’t happen often. You could have hundreds of perfectly focused images in your phone and just one that is out of focus.

Oddly enough, genetics works in essentially the same way as selfies. Genes play the role of the tiny pixels that collectively make up the image of our inner self. They’re the building blocks that make us who we are. Genes determine our eye color, hair color and a host of other things including an influence on our behavior. When genes function the way that they should, the image they project can appear focused – sharp and crisp to the naked eye. Conversely, a gene that does not function adequately can make the resulting image seem a bit blurred and at times surreal.

Where genes and pixels differ, is that just one gene variation or single-nucleotide polymorphism (SNP) out of twenty billion can change the entire picture. That is not a typo; one out of twenty billion! To give you a sense of scale, a single molecule is so small that it would get lost on the sharp tip of a pin. It’s hard to imagine that something so small could have such an outsized effect, but it does. As tiny as these gene SNPs may be, they’re powerful enough to influence a person’s potential to abuse drugs and/or alcohol or engage in other risky behaviors; ergo, blur the selfie.

There is another factor that influences a person’s addiction risk that needs to be taken into consideration in order to be able to view the complete image. In recent years, researchers and doctors have found that environment plays a larger role in influencing risky behavior – such as substance and/or non-substance use disorders. Parenting, family, friends, education, religion, economics and other factors found in one’s environment has a direct influence on a person’s vulnerability to addiction by as much as 50%.

However, all experts agree that early insight into one’s risk of susceptibility to drug and/or alcohol abuse and/or other destructive 12 behaviors can have a profound effect on outcomes. Until recently, there wasn’t any type of technology available to the public that was capable of making such a determination with reliable accuracy. But just as smartphone cameras have evolved and become better over time, the technology behind genetic analysis has also dramatically improved in the most recent years. These technological advancements, combined with over 40 years of vigorous science and research, have made it possible to view the once hidden drivers of behavioral predisposition and addiction in HD.

Every picture tells a story.
The Genetic Addiction Risk Score (GARS™) is, for all intent and purposes, a genetic selfie – an HD snapshot that in real time reveals your genetic risk to addiction and other behaviors. Through a simple cheek swab, this revolutionary new diagnostic zooms in on genetic markers – or in this context, the pixels that blur the image – known to influence addictive behavior, and then sizes them up. Once all the qualitative and quantitative information is retrieved, it’s fed into a proprietary algorithm that brings the background into focus. The result is a crystal clear genetic selfie showing where you stand against the backdrop of your risk and vulnerability to drugs, alcohol or other substances and/or non-substance behaviors.

This innovative platform is firmly based upon the life’s work of Dr. Kenneth Blum, co-discoverer of the first known addiction gene. Forty years of extensive worldwide research into addiction, mental health and brain chemistry, consisting of countless papers and clinical trials published in peer reviewed medical journals – including the Journal of the American Medical Association (JAMA) – provided the strong foundation for Dr. Blum along with Geneus Health to bring the GARS™ test to the world.

It is important to note that your genetic selfie is not a permanent prediction of your future; but rather an indication of what could emerge. Keep in mind that environment plays an equal part in this equation. In fact, there are millions of people who have genetic predispositions to addiction that never abused drugs and/or alcohol because of the influence their environment has on them.

This relatively new technology has created a whole new genre in preventing addiction!
GARS™ is a game-changer. This genetic selfie tells the underlying story of susceptibility to addiction in real time with exact precision; a story that often was merely guessed at in the past. This state-of-the-art diagnostic empowers its users by providing life-changing health information that can guide future choices. It has changed the way we treat ourselves and the people closet to us.

GARS™ can tell the ‘propensity to addiction’ story long before someone begins abusing drugs, alcohol or other substances and/or non-substance behaviors.
People tell us all the time how they’ve successfully navigated through challenging times using their GARS™ results as a compass. Proactive parents are having their children tested so that they can correct any environmental issues that could negatively influence their kids before an addiction begins. One of the most fascinating non-substance behaviors uncovered for children and adolescents is online gaming. Many addicts in recovery tell us they wished they had known this information way back when – before they began experimenting with drugs, alcohol or other items.

As groundbreaking as GARS™ is, the diagnostic is just part of the transformative Precision Addiction Management (PAM™) platform developed by Dr. Blum in collaboration with Geneus Health.

GARS™ plays the role of identifying the genes – fuzzy pixels – that influence
addiction and other behaviors, but that only tells you the issue. With this invaluable information provided by GARS™, Dr. Blum and Geneus Health have customized a patented, genetically guided therapy called restoreGen™. restoreGen™ is a pro-dopamine regulator that consists of six different neuro-nutrient formulations that supplement genetic dysfunction and rebalance brain chemistry. Each restoreGen™ formulation is tailored to the genetic outcomes of the individual’s GARS™ report.

If there was a genetic version of Photoshop, restoreGen™ would be it. This pioneering new technology takes the genetic deficits – fuzzy pixels – identified by the GARS™ test and sharpens their image while reshaping them into more of their original contour. In a short period of time the genes begin to function normally as they were intended to.

Anyone who has a genetic predisposition to at-risk behaviors or addiction can benefit from the restoreGen™ neuro-nutrients. Dozens of published clinical studies validate this neuro-nutrient technology in rebalancing brain chemistry showing to help with:

• Reducing addictive cravings
• Optimizing brain health
• Increasing focus
• Enhancing energy
• Relieving stress
• Improving overall well-being

restoreGen™ neuro-nutrients – which have been used to manage addiction recovery in leading treatment centers across the country for years – have been scientifically proven to reduce or eliminate excessive desires for unhealthy behaviors and pleasure-inducing substances.

Since knowledge is power, the transformative Precision Addiction Management (PAM™) is a super-power. It takes all the guesswork out of the calculus. No more “what if?” or “should I?” GARS™ provides you with a genetic selfie that shows if you or your loved one has a genetic predisposition to self-destructive behaviors. Anyone with a default setting pointing to addictive and/or destructive behaviors, or has a loved one who does, needs to carefully examine all the life changing attributes PAM™ provides. Many addiction treatment centers across the U.S. are finding GARS™ and restoreGen™ to be a great complimentary component to current treatment regimens, enhancing both the treatment and recovery process.

All tests are 100% confidential.

Whoever said ‘a picture is worth a thousand words could never have imagined the impact a GARS™ genetic selfie could have in helping to fight this horrific drug addiction epidemic we find ourselves in today.

To learn more about Geneus Health, please visit us at For more about Dr. Blum, please visit:

Kenneth Blum, B.Sc. (Pharmacy), M.Sc., Ph.D. & DHL; received his Ph.D. in Neuropharmacology from New York Medical College and graduated from Columbia University and New Jersey College of Medicine. He also received a doctor of humane letters from Saint Martin’s University Lacey, WA. He has published more than 550 abstracts; peer-reviewed articles and 14-books.

Dr. Siwicki is board certified in emergency medicine and is also certified in addiction medicine. Dr. Siwicki was the co-founder of Dominion Diagnostics LLC; North Kingston, RI which is now the largest privately held toxicology laboratory in the U.S. Dr. Siwicki is also the co – founder of Geneus Health, LLC. He serves as Presi-dent of Geneus Health and Igene LLC and is a member of Board of Directors on Dominion Diagnostics.

Justin Jones is a graduate of Texas State University with a M.B.A. from Post University Malcolm Baldridge School of Business. He is a certified healthcare finance professional with HFMA. Justin has 19 years of experience in executive management, marketing, mergers and acquisitions, and many other roles with both Fortune 500 and small specialized companies. Justin also has a diverse business background in both the U.S. and internationally, including China, Canada, Mexico, and the United Kingdom. Justin is a published au-thor of the Powerhouse Interviewing Workbook and has presented at numerous speaking engagements and seminars.